sts/acc tvt registry v2 - ncdr.com · sts/acc tvt registry tm v2.0 ... o leaflet clip o direct...
TRANSCRIPT
STS/ACC TVT RegistryTMv2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
If Yes, MV Replacement – Surgical4100
:
Mitral Valve or Ring Model ID4116
:
If Yes, MV Type4105
: O Bioprosthetic stentedO Bioprosthetic stentless O Not Documented
© 2011 STS and ACCF 3/4/2015 4:52 PM Page 1 of 9
If Yes, MV Replacement Model ID4106
: ___________________Refer to Device List
Last Name2000: First Name2010: Middle Name2020:
SSN2030: - - □ SSN N/A2031Patient ID2040: (auto) Other ID2045:
Birth Date2050
:
□ White2070 □ Black/African American2071 □ Asian2072
□ American Indian/Alaskan Native2073
□ Native Hawaiian/Pacific Islander2074
Race:
(check all that apply)
Sex2060: Hispanic or Latino Ethnicity2076: O No O YesO Male O Female
A. DEMOGRAPHICS
mm / dd / yyyy
Arrival Date/Time3000,3001:
B. EPISODE OF CARE
mm / dd / yyyy HH:MM
□ Private Health Insurance3005
□ Medicare3006
□ Medicaid3007
□ Military Health Care3008
□ State-Specific Plan (non-Medicaid)3009
□ Indian Health Service3010
□ Non-US Insurance3011
□ None3012
Insurance Payors:
(check all that apply)
Research Study3030
: If Yes, Study Patient ID3032
:HIC3015
: O No O Yes
C. HISTORY AND RISK FACTORS (PATIENT HISTORY AND RISK FACTORS UP TO THE PROCEDURE)
Prior CABG4030
:
Permanent Pacemaker4010:
O No O Yes
O No O Yes
O No O Yes
Infective Endocarditis4000:
Prior Aortic Valve Procedure4060
: O No O Yes
Previous ICD4015: O No O Yes
Prior PCI4020
:
CARDIAC HISTORY
# Previous Cardiac Surgeries4055
: O 0 O 1 O 2 O 3 O >=4
If Yes, Most Recent MV Procedure Date4097
: mm / dd / yyyy
If Yes, MV Transcatheter Intervention4112
:
O Leaflet clip O Direct annuloplasty intervention
O Coronary sinus based intervention O Valve-in-native Valve
O Valve-in-Valve O Other
If Yes, Mitral Transcather Type4113
:
If Yes, MV Repair – Surgical4110
:
If Yes, Prior Tricuspid Valve
Repair/Replacement4118
:
If Yes, Mitral Annuloplasty Ring – Surgical4111
:
O No O Yes – partial
O Yes – circumferential O Not Documented
If Yes, Prior Pulmonic Valve
Repair/Replacement4119
:
If Yes, CRT4013
:
If Yes, CRT–D4016
:
O No O Yes
O No O Yes
Heart Failure Hospitalization w/in Past Year4006:
O No O Yes
O No O Yes
O No O Yes
If Yes, AV Replacement – Surgical4070
:
If Yes, AV Transcatheter Valve
Replacement4090
:
O No O YesIf Yes, AV Repair – Surgical4080
:
O No O Yes O Not Documented
Prior Non-Aortic Valve Procedure4095:
Residence3003
: O Home w/no health-aid O Home w/health-aid O Long-term care O Other O Not Documented
Prior Stroke4120
:
If Yes, Most Recent Stroke Date4125
: mm / dd / yyyy
O No O YesDiabetes Mellitus4165
:
If Yes, Diabetes Therapy4170
:
O None O Diet O Oral O Insulin O Other
OTHER HISTORY AND RISK FACTORS
Transient Ischemic Attack4130
:
If Yes, Infective Endocarditis Type4005: O Treated O Active
O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
___________________Refer to Device List
STS/ACC TVT RegistryTMv2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
OTHER HISTORY AND RISK FACTORS
© 2011 STS and ACCF 3/4/2015 4:52 PM Page 2 of 9
Immunocompromise Present4185
:
Peripheral Arterial Disease4145
:
Hypertension4155
: O No O Yes
Current Smoker4150
(w/in 1 year):
Currently on Dialysis4175
:
Chronic Lung Disease4180
: O None O Mild O Moderate O Severe
Home Oxygen4181
: O No O Yes
Carotid Stenosis4135
: O None O Right O Left O Both O NA
If Yes, Prior CEA/CAS4140
:
Hostile Chest4182
: O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
If Loop Diuretic, Dose4210
:_____mg
HOME MEDICATIONS
ACE or ARB (any)4200,4205
: Diuretics – Aldosterone Antagonists4200,4205
:
Diuretics – Loop diuretic4200,4205
:
Diuretics – Thiazides4200,4205
:
Diuretics (not otherwise specified)4200,4205
:
Anticoagulants (any)4200,4205
:
Aspirin (alone)4200,4205
:
Aspirin (dual antiplatelet therapy)4200,4205
:
Beta Blockers (any)4200,4205
:
O No O Yes O No O Yes
O No O Yes O No O Yes
O No O Yes
O No O Yes O No O Yes
O No O Yes O No O Yes
D. PRE-PROCEDURE STATUS (COMPLETE FOR THE PROCEDURE)
Heart Failure w/in 2 Weeks5020
:
NYHA Class w/in 2 Weeks5025
:
Cardiogenic Shock w/in 24 Hours5030
:
Cardiac Arrest w/in 24 Hours5035
:
Atrial Fibrillation/Flutter5050: O No O Yes
O I O II O III O IV
_______ %
If Yes, AF Class w/in past 30 days5052: O None O Persistent O Paroxysmal
CAD Presentation5000
: O No Sxs, no angina (14 days) O Sx unlikely to be ischemic (14 days) O Stable angina (42 days)
O Unstable angina (60 days) O Non-STEMI (7 days) O STEMI (7 days)
Prior MI5005
: If Yes, Prior MI Timeframe5010
: O < 30 Days O >= 30 days
Cardiomyopathy5012
: O No O Yes – Ischemic O Yes – Non-ischemic
mm / dd / yyyy
Total Distance5117
: ___________ ft
Six Minute Walk Test5115
:
O Performed
O Not performed – non-cardiac reason
O Not performed – cardiac reason
O Not performed – patient not willing to walk
O Not performed by site
STS Risk Score (MV replace)5106
:
Test Date5116
:
(See separate questionnaire)
If Yes, KCCQ-125170-5181
:
KCCQ-12 Performed5169
: O No O Yes
Q1a: _______ Q1b: _______ Q1c: _______ Q2: _______ Q3: _______ Q4: _______
Q5: _______ Q6: _______ Q7: _______ Q8a: _______ Q8b: _______ Q8c: _______
Porcelain Aorta5045:
O No O Yes
O No O Yes
O No O Yes
O No O Yes
O No O Yes
Height5200
: Weight5205
:
CLINICAL DATA (CLOSEST TO THE PROCEDURE)
___________ cm ___________ kg
Creatinine5255
:
Hemoglobin5250
:
□ Not Drawn5256
□ Not Drawn5251_______ g/dL
_______ mg/dL
FEV1 Predicted5280
:_______ %
DLCO (Adjusted)5285
: _______ %
□ Not Performed5281
□ Not Performed5286
BNP5277
: ______ pg/mL (OR) NT proBNP5278
: _____ pg/mL
□ Not Drawn5279
QRS Duration5290
: □ Ventricular Paced5291________ msec
MEDICATIONS (ADMINISTERED WITHIN 24 HOURS PRIOR TO THE PROCEDURE)
Inotropes5400,5405
(positive): O No O Yes O Contraindicated O Blinded
Left Ventricular Internal Systolic Dimension5595
:
Left Ventricular Internal Diastolic Dimension5600
:
______ cm
© 2011 STS and ACCF 3/4/2015 4:52 PM
Aortic Regurgitation5630
(highest):
Left Atrial Volume5606
: ____ ml (OR) LA Volume Index5607
: _____ mL/m2
Left Ventricular End Diastolic Volume5603
:
Left Ventricular End Systolic Volume5601
:
Aortic Stenosis5665
: O No O Yes
MV Area5710
: MV Mean Gradient5715
(highest): ________ cm2
________ mmHg
______ ml
______ ml
STS/ACC TVT RegistryTMv2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
□ Not Measured5604
□ Not Measured5602
Effective Orifice Area (EOA) or EROA 5698
: ________ cm2
ECHOCARDIOGRAM FINDINGS
Page 3 of 9
If Prior MV Replacement, Paravalvular Severity5696
: O None O Mild O Moderate O Severe O Not Documented
If Prior MV Replacement, Valvular Severity5697
:
If Prior Prosthetic MV, Prosthetic Mitral Valve Dysfunction Etiology5742
:
O Primary/degenerative bioprosthetic Valve Failure O Pannus formation O Thrombus formation O Other
□ Not Measured5608
□ Not Measured5609
Mitral Valve Disease5685
: O No O Yes If Yes, complete the following:
MV Valve Stenosis5705
: O No O Yes
Tricuspid Regurgitation5735
: O None O Trace/Trivial O Mild O Moderate O Severe
DIAGNOSTIC CATH FINDINGS
LVEF5565
: □ LVEF Not Assessed5566
Right Atrial Pressure/CVP (mean)5598
:
Pulmonary Capillary Wedge Pressure5590
:
_________ mmHg
_________ mmHg
________ %
Left Main Stenosis >=50%5507
:
Number of Diseased Vessels5506
: O None O 1 O 2 O 3
Pulmonary Artery Pressure (systolic)5596
:
□ Not Performed5569
Pulmonary Artery Pressure (mean)5593
:
Cardiac Output5567
:
_________ mmHg
_________ mmHg
_________ L/min
□ Not Measured5591
□ Not Measured5594
□ Not Measured5597
□ Not Measured5599
O No O Yes
______ cm
O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3-4+ (severe)
Mitral Regurgitation5695
(highest): O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe) O 4+ (severe)
O None O Mild O Moderate O Severe O Not Documented
Method of Assessment5699
: O 3D Planimetry O PISAO Quantitative Doppler O Other
Mitral Valve Disease Etiology (check all that apply):
If DMR is Yes, Leaflet Prolapse5760:
If DMR is Yes, Leaflet Flail
5765:
If Inflammatory is Yes, Type
5770:
If FMR is Yes, Functional Type
5755:
□ Degenerative Mitral Regurgitation (DMR)5746
□ Endocarditis5748
□ Functional Mitral Regurgitation (FMR)5745 □ Post – Inflammatory5747
□ Other/Indeterminate5749
O None O Anterior O Posterior O Bi-leaflet O Not Documented
O Ischemic-acute, post infarction O Ischemic-chronic O Non-ischemic dilated cardiomyopathy
O Restrictive cardiomyopathy O Hypertrophic cardiomyopathy
O Pure annular dilation (w/normal LV systolic fx) O Not Documented
O Idiopathic O Prior radiation Rx O Collagen vascular disease
O Drug induced O Rheumatic fever history O Not Documented
O None O Anterior O Posterior O Bi-leaflet O Not Documented
ECHOCARDIOGRAM FINDINGS CONT’D
Procedure Start Date/Time6040,6041
: Procedure Stop Date/Time6045,6046
:mm / dd / yyyy HH:MM mm / dd / yyyy HH:MM
Procedure Status6055
: O Elective O Urgent O Emergency O Salvage
© 2011 STS and ACCF 3/4/2015 4:52 PM
Type of Anesthesia6110
: O General anesthesia O Moderate sedation O Epidural O Combination
Procedure Access Site29180
: O Transseptal O Transapical O Direct left atrium O Femoral artery O Other
STS/ACC TVT RegistryTM
v2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
Page 4 of 9
Procedure Aborted29120
:
O Access related O Navigation issue after successful access
O New clinical findings O Device/delivery system malfunction
O Patient clinical status O Consent issue
O Transseptal access related O System issue
O Other (not specified)
O No O Yes
If Yes, Reason29125
:
Operator Reason for Procedure29115
: O Inoperable/Extreme risk (technically inoperable, co-morbid or deconditioned patient)
O High risk (>=8% risk of 30 day mortality)
O Intermediate risk (4-7% risk of 30 day mortality)
O Low risk (<4% risk of 30 day mortality)
If Yes, Action29127
: O Balloon valvuloplasty O Rescheduled transcatheter procedure
O Conversion to open heart surgery O Converted to medical therapy
O Converted to clinical trial O Open heart surgery scheduled O Other
Mitral Leaflet Calcification5810
:
Leaflet Tethering5775
:
Mitral Annular Calcification5800
:
Procedures:
Conversion to Open Heart Surgery29130
: O No O Yes
If Yes, Reason29135
: O Access related problem/injury O Inability to position device O Valve injury
O Device embolization O Tamponade/bleeding in the heart O Other
Mechanical Assist Device29140
:
If Yes, Type29146:
CardioPulmonary Bypass Used6100
: O No O Yes If Yes, Status6101: O Elective O Emergent
O No O Yes
If Yes, CPB Time 6105:
If Yes, Timing29145:
Pre-Implant Balloon Inflation Performed29185
:
If Yes, Significant Hemodynamic Deterioration After Inflation29190:
O No O Yes
O No O Yes
Other Procedure Performed Concurrently6620
: O No O Yes – PCI O Yes – Other
□ Transcatheter Aortic Valve Replacement6600 □ Transcatheter Mitral Valve Replacement
6601 □ Mitral Leaflet Clip Procedure6602
O None O Anterior O Posterior O Bi-leaflet O Not documented
O Yes O No O Not documented
O Yes O No O Not documented
E. PROCEDURE INFORMATION (COMPLETE FOR EACH MITRAL VALVE-IN-VALVE OR VALVE-IN-RING PROCEDURE)
O Pre-procedure O Intraprocedure O Postprocedure
O IABP O Catheter-based assist device
______ mins
Operator A Name6000,6005,6010
: Operator A NPI6015
:
Operator B Name6020,6025,6030
: Operator B NPI6035
:
Additional Procedures
Bleed/Vascular
Neuro
Renal
Device
Cardiac
© 2011 STS and ACCF 3/4/2015 4:52 PM
F. ADVERSE EVENTS, INTERVENTIONS AND SURGERIES (COMPLETE FOR EACH PROCEDURE. SPECIFY EVENT DATE FOR EACH EVENT OCCURRENCE.)
Cardiac ArrestE005
:
Myocardial InfarctionE059:
EndocarditisE003
:
Perforation w/ or w/o TamponadeE009
:
Device ThrombosisE027
:
Other Device Related EventE028
:
Bleeding at Access SiteE017
:
Retroperitoneal BleedingE019
:
Hematoma at Access SiteE018
:
GI BleedE020
:
GU BleedE021
:
Other BleedE022
:
Transient Ischemic AttackE010
(complete Adjudication):
Ischemic StrokeE011
(complete Adjudication):
Atrial Fibrillation (new onset)E006
: mm / dd / yyyy
New Requirement for DialysisE029
:
mm / dd / yyyy
Hemorrhagic StrokeE012
(complete Adjudication):
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
Stroke (Undetermined Type)E013
(complete Adjudication):
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
Intra or Post Procedure Events Occurred7300
: O No O Yes If Yes, specify the Event7301
and Event Date(s)7302
:
mm / dd / yyyy
Major Vascular ComplicationE041
:
Transseptal Related EventE052
:
Minor Vascular ComplicationE042
:
Device EmbolizationE050
:
STS/ACC TVT RegistryTM
v2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
Fluoroscopy Time6460
:
Dose Area Product6470
: O Gy-cm2O cGy-cm
2O mGy-cm
2O µGy-M
2
Radiation Dose Measurement Method6455
: O Single Plane O Biplane
_______ mGy
_______ DAP Units6475
:
Cumulative Air Kerma6465
:
_______ mins
MV Mean Gradient29290
(highest): ________ mmHg
Page 5 of 9
Conduction/Native Pacer
Disturbance Req PacerE039
:
Conduction/Native Pacer
Disturbance Req ICDE040
:
LVOT ObstructionE044
:
Device MigrationE023
:
Device Recapture or RetrievalE026
: Transapical Related EventE014:
mm / dd / yyyy
ASD Closure
Due To Transseptal CatheterizationE054:
Mitral Valve Re-interventionE053
(complete Adjudication):
Unplanned Other Cardiac Surgery or InterventionE031
(not MVR):
Unplanned
Vascular Surgery or InterventionE032
(for Bleeding or Access Site Complication):
mm / dd / yyyy
POST IMPLANT
Device 1 Used29201
:
Device 2 Used29201
:
__________________________ Device Serial Number29205
:
PROSTHETIC VALVE/DEVICE INVENTORY
Refer to Device List
(future)UDI29210, 29215, 29220
:
Device Implanted Successfully29225
:
Contrast Volume29295
:
Post-Implant Balloon Inflation Performed29195: O No O Yes
__________________________Refer to Device List O No O Yes
__________________________
Mitral Regurgitation26285
: O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe) O 4+ (severe)Note: According to American Society of Echocardiography Guidelines
_______ ml
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
Mitral Regurgitation8075
:
Lowest Hemoglobin8040
: _______ g/dL ______ mg/dLHighest Creatinine8050
:
Echocardiogram8065
: O Not Performed O Yes - TTE O Yes - TEE If Yes, complete the following:
mm / dd / yyyy
Mean Mitral Gradient8130
(highest): ________ mmHg
G. POST-PROCEDURE LABS AND TESTS
□ Not Drawn8041 □ Not Drawn
8051
© 2011 STS and ACCF 3/4/2015 4:52 PM
Date8070
:
Effective Orifice Area (EOA) or EROA 8122
: ________ cm2
Page 6 of 9
Systolic Anterior Motion Present8145
: O No O Yes
LVOT gradient (peak)8140
:
If Trace/Trivial, Mild, Moderate, or Severe, Paravalvular Severity8112
: O None O Mild O Moderate O Severe
O Not Documented
If Trace/Trivial, Mild, Moderate, or Severe, Valvular Severity8115
:
Method of Assessment8125
: O 3D Planimetry O PISA O Quantitative Doppler O Other
STS/ACC TVT RegistryTMv2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
Mitral Valve Area8135
:
12-Lead ECG Findings8060
: O Not performed O No significant changes O New pathological Q-wave or LBBB
O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe) O 4+ (severe)
Note: According to American Society of Echocardiography Guidelines
O None O Mild O Moderate O Severe
O Not Documented
________ mmHg _______ cm2
Discharge Date9045
: Discharge Status9050
:
If Deceased, Death in Lab/OR9060:
O Alive O Deceased
O No O Yes
If Deceased, Primary Cause of Death9065: O Cardiac O Neurologic O Renal O Vascular O Infection
O Valvular O Pulmonary O Unknown O Other
mm / dd / yyyy
If Alive, Discharge Location9055: O Home O Extended care/TCU/rehab O Other acute care hospital
O Nursing home O Hospice O Other O Left against medical advice (AMA)
Number of Hours in ICU9040
:
O No O Yes If Yes, # Units Transfused9012
: ________RBC/Whole Blood Transfusion9011
:
H. DISCHARGE (COMPLETE FOR EACH EPISODE OF CARE)
________
Note: Code the total # of units between start
of the procedure and discharge
DISCHARGE MEDICATIONS (NOT REQUIRED FOR PTS WHO EXPIRED OR WERE DISCHARGED TO ‘OTHER ACUTE CARE HOSPITAL’, ‘HOSPICE’, OR ‘AMA’)
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
ACE/ARB9100,9105
(any):
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
Aspirin (alone)9100,9105
:
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
Diuretics – Loop9100,9105
:
Diuretics – Thiazides9100,9105
:
Diuretics – Aldosterone Antagonists9100,9105
:
Diuretics (not otherwise specified)9100,9105
:
Aspirin (dual antiplatelet therapy)9100,9105
:
Beta Blockers (any)9100,9105
:
If Loop Diuretic, Dose9110
:
Anticoagulants (any)9100,9105
O No O Yes O Contraindicated O Blinded
_____mg
© 2011 STS and ACCF 3/4/2015 4:52 PM
STS/ACC TVT Registry™ v2.0Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
Page 7 of 9
Systolic Anterior Motion Present10375: O No O Yes
LVOT gradient (peak)10370
: ______mmHg
Last Name2000: First Name2010:
NYHA Classification at Follow-up10100
: O I O II O III O IV
Status10010
: O Alive O Deceased O Lost to follow-up O Withdrawn
Assessment Date10000:
Reference Procedure Start Date6040:
Patient ID2040:
I. FOLLOW-UP (30 DAYS, 1 YEAR FROM DATE OF PROCEDURE)
mm / dd / yyyy
mm / dd / yyyy
Primary Method to Determine Status10005: O Clinic O Medical record O Letter from medical provider
O Phone call to patient/family O Social Security death master file O Other
If Deceased, Primary Cause of Death10015
:
If Deceased, Date of Death10020
: mm / dd / yyyy
_______ mg/dLHemoglobin10085
: _____ g/dL Creatinine10090
:
Other ID2045:
□ Not Drawn10091□ Not Drawn10086
LVEF10210
:
Echocardiogram10206
: O Not Performed O Yes - TTE O Yes - TEE If Yes, complete the following
□ LVEF Not Assessed10211
________ %
Study Patient ID3032
:
(See separate questionnaire)
If Yes, KCCQ-1210231-10243
:
(optional)
mm / dd / yyyy
KCCQ-12 Performed10230
: O No O Yes
Q1a: _______ Q1b: _______ Q1c: _______ Q2: _______ Q3: _______ Q4: _______
Q5: _______ Q6: _______ Q7: _______ Q8a: _______ Q8b: _______ Q8c: _______
(If the patient has not been discharged at 30 days, capture the 30 day F/U while still in the facility.)
Residence10008
: O Home w/no health-aid O Home w/health-aid O Long-term care O Other O Not documented
Six Minute Walk Test Performed10380
:
Test Date10385
:
Total Distance Walked10390
: __________ ft
mm / dd / yyyy
O Performed O Not performed – non-cardiac reason
O Not performed – cardiac reason
O Not performed – patient not willing to walk
O Not performed by site
Mitral Regurgitation10300
:
Mean Mitral Gradient10330
: ________ mmHg
O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe) O 4+ (severe)
Method of Assessment10320
:Effective Orifice Area (EOA) or EROA 10315
: ________ cm2
Left Ventricular Internal Systolic Dimension10345
:
Left Ventricular Internal Diastolic Dimension10350
:
________ cm
________ cm
Left Atrial Volume10335
: ____ mL (OR) LA Volume Index10340
: _____ mL/m2
Left Ventricular End Diastolic Volume10360
:
Left Ventricular End Systolic Volume10355
: ________ mL
________ mL
Tricuspid Regurgitation10365
: O None O Trace/Trivial O Mild O Moderate O Severe
Note: According to American Society of Echocardiography Guidelines
O 3D Planimetry O PISA O Quantitative Doppler O Other
□ Not Measured10346
□ Not Measured10351
□ Not Measured10356
□ Not Measured10361
Date10207
:
O Cardiac O Neurologic O Renal O Vascular O Infection
O Valvular O Pulmonary O Unknown O Other
If Trace/Trivial, Mild, Moderate, or Severe, Paravalvular Severity10305
: O None O Mild O Moderate O Severe
O Not Documented
If Trace/Trivial, Mild, Moderate, or Severe, Valvular Severity10310: O None O Mild O Moderate O Severe
O Not Documented
Mitral Valve Area10325
: ________ cm2
Bleeding/Vascular
© 2011 STS and ACCF 3/4/2015 4:52 PM
STS/ACC TVT RegistryTMv2.0
Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
Page 8 of 9
Renal
Readmission
Additional Procedures
Device
Neuro
Cardiac
I. FOLLOW-UP (CONT.) (30 DAYS, 1 YEAR FROM DATE OF PROCEDURE)
Myocardial InfarctionE059
:
Life Threatening BleedingE037
:
New Requirement for DialysisE029
:
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
EndocarditisE003
:
O No O Yes O Contraindicated O Blinded
ADVERSE EVENTS, READMISSIONS, INTERVENTIONS AND SURGICAL PROCEDURES (SPECIFY THE EVENT DATE FOR EACH EVENT THAT OCCURRED
BETWEEN DISCHARGE AND 30-DAY F/U, OR BETWEEN F/U ASSESSMENT DATE #1 AND F/U ASSESSMENT DATE #2.)
Readmission – Cardiac (not HF)E056
:
Unplanned Other Cardiac Surgery or Intervention
E031(not Mitral):
Mitral Valve Re-interventionE053
(complete Adjudication): Ischemic StrokeE011
(complete Adjudication):
Hemorrhagic StrokeE012
(complete Adjudication):
Stroke (Undetermined Type) E013
(complete Adjudication):
O No O Yes If Yes, specify the Event10246
and Event Date(s)10247
:
Unplanned Vascular Surgery
or InterventionE032
(for Bleeding or Access Site Complication):
Transient Ischemic AttackE010
(complete Adjudication):
Major Vascular ComplicationE041
:
Readmission – Heart FailureE055
(complete Adjudication):
Minor Vascular ComplicationE042
:
Major Bleeding EventE043
:
Atrial Fibrillation (new onset)E006
:
ASD Closure
Due To Transeptal CatheterizationE054
:
Device Embolization E050
:
Other Device Related EventE028
:
FOLLOW-UP MEDICATIONS (MEDICATIONS PRESCRIBED OR TAKEN AT THE TIME OF FOLLOW-UP)
ACE/ARB10250,10255
(any):
Diuretics – Loop10250,10255
:
Diuretics – Aldosterone Antagonists10250,10255
:
Beta Blockers10250,10255
(any):
If Loop Diuretic, Dose10257:
Readmission – Non-Cardiac
(Follow Up)E057
:
Follow-up Events Occurred10245
:
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
Aspirin10250,10255
(alone):
Diuretics – Thiazides10250,10255
:
Diuretics (not otherwise specified)10250,10255
:
Aspirin (dual antiplatelet therapy)10250,10255
:
Anticoagulants10250,10255
(any):
O No O Yes O Contraindicated O Blinded
_____ mg
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
O No O Yes O Contraindicated O Blinded
O No O Yes O Contraindicated O Blinded
Device FractureE038
:
Device MigrationE023
:
Device ThrombosisE027
: mm / dd / yyyy
Transapical Related EventE014
:
mm / dd / yyyy
Conduction/Native Pacer
Disturbance Req PacerE039
:
Conduction/Native Pacer
Disturbance Req ICDE040: mm / dd / yyyy
mm / dd / yyyy
© 2011 STS and ACCF 3/4/2015 4:52 PM
STS/ACC TVT Registry™ v2.0Transcatheter Mitral Valve-in-Valve or Valve-in-Ring Procedure
If Event12000
is Stroke or TIA
Neurologic Deficit with Rapid Onset12020
:
Date of Symptom Onset12015
(approximate):
If Stroke/TIA, Symptom Duration > 24 hours12030
:
If Yes, Clinical Presentation12025
:
If Stroke/TIA, Neuroimaging Performed12040
:
If Stroke/TIA, Death as a Result of Neurologic Deficit12060
:
If Stroke/TIA, Neurologist/Neurosurgeon Confirmation of Diagnosis12055
:
Clinical Comments12065
(information and details that may assist in assessing the stroke or TIA):
O No O Yes
mm / dd / yyyy
O Stroke/TIA O Non-Stroke
O No O Yes
O No O Yes
O No O Yes
O No O Yes
Mitral Valve Re-intervention Type12200
:
If Other Transcatheter Intervention, Other Type12205:
O Surgical MV Repair O Surgical MV Replacement O Transcatheter MV Repair
O Transcatheter MV Replacement O Leaflet Clip Procedure O Other Transcath Intervention
Clinical Comments12220
(information and details that may assist in assessing this re-intervention):
O Mitral regurgitation O Mitral stenosis O Mitral valve injury
O Device embolization O Endocarditis O Device thrombosis O Other
MV Reintervention Indication12210
:
If Other, Other Indication12215
: __________________________________________________________________________
______________________________________________________________
Adjudication Event12000
: O Ischemic Stroke(In-hospital) O Hemorrhagic Stroke(In-hospital) O Undetermined Stroke(In-hospital) O TIA(In-hospital)
O Mitral Valve Re-intervention(In-hospital)
O Ischemic Stroke(F-U) O Hemorrhagic Stroke(F-U) O Undetermined Stroke(F-U) O TIA(F-U)
O Mitral Valve Reintervention(F-U)
O Readmission – Heart Failure (F-U)
mm / dd / yyyy If Deceased, Date of Death12011
:Status12010
: O Alive O Deceased
Last Name2000
: First Name2010
:
Reference Procedure Start Date6040
: mm / dd / yyyy Other ID2045
:
Patient ID2040
:
Study Patient ID3032
:
J. ADJUDICATION FORM (COMPLETE FOR EACH STROKE, TIA, MITRAL VALVE RE-INTERVENTION, OR HEART FAILURE READMISSION)
Event Date12005
:
(optional)
If Event12000
is Mitral Valve Re-intervention
mm / dd / yyyy
If Stroke/TIA, Social/Recreational Activities Impaired12056
:
If Stroke/TIA, Neurocognitive Functions Essential to Pt or their Livelihood Impaired:12057
:
If Stroke/TIA, New Aids or Assistance Required:12058
:
O No O Yes
O No O Yes
O No O Yes
If Event12000
is Readmission (Heart Failure)
If Yes, Deficit Type12045
: O No deficit O Infarction O Hemorrhage O Both (hem/infarc) O Subarachnoid Hemorrhage
O No O Yes O Information not availableHospitalization >=24 hours12225
:
Clinical Signs and/or Symptoms of Heart Failure12230
:
Note: IV includes diuretics or vasoactive therapy and Invasive includes ultrafiltration, IABP, or mechanical assistance
IV or Invasive Treatment Required12335
:
O No O Yes O Information not available
O No O Yes O Information not available